Qing Xiang

Prediction of potent shRNAs with a sequential classification algorithm

Raphael Pelossof, Lauren Fairchild, Chun‐Hao Huang et al. · Nature Biotechnology · 2017 · 196 citations

Functional Genomics, Engineering, Genetics +8

Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells

Elliott J. Brea, Claire Y. Oh, Eusebio Manchado et al. · Cancer Immunology Research · 2016 · 174 citations · Full text

Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), A Potent and Selective Cyclin-Dependent Kinase Inhibitor with Significant in Vivo Antitumor Activity

Xin‐Jie Chu, Wanda DePinto, David Bartkovitz et al. · Journal of Medicinal Chemistry · 2006 · 116 citations · Full text

Drug Target, Pharmacotherapy, Cell Cycle +17

<i>In vitro</i> and <i>in vivo</i> activity of R547: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials

Wanda DePinto, Xin‐Jie Chu, Xuefeng Yin et al. · Molecular Cancer Therapeutics · 2006 · 102 citations · Full text

Molecular Pharmacology, Tumor Biology, Cell Cycle Block +15

Effects of Notch Signaling Pathway in Cervical Cancer by Curcumin Mediated Photodynamic Therapy and Its Possible Mechanisms in Vitro and in Vivo

Guifang He, Tianlong Mu, Yali Yuan et al. · Journal of Cancer · 2019 · 60 citations · Full text